Professional Documents
Culture Documents
Brand Name: Verorab Contents: Indication / Action
Brand Name: Verorab Contents: Indication / Action
Indication / Action: Pre-Exposure Immunization: Verorab is particularly recommended for: Professional groups
exposed to frequent contamination: Veterinary surgeons including students at veterinary colleges, technical
personnel working with veterinary surgeons, laboratory personnel handling material contaminated with rabies virus,
personnel in abattoirs and knacker's yard, taxidermists, gamekeepers, forestry workers and naturalists in enzootic
areas. Infants particularly exposed to the risk of rabies.
Post-Exposure Immunization: Treatment of subjects bitten by rabid animals or those suspected of being so.
Treatment of contact subjects.
Dosage: Pre-exposure 3 inj D0, D7 & D28, booster 1 yr later, & then 5 yrly (WHO experts). Post-exposure In
subjects unvaccinated against rabies: IM-schedule 5 x 0.5 mL on days D0, D3, D7, D14 & D30. ID-schedule2 x 0.1
mL at different sites on days D0, D3, D7 & 1 x 0.1 mL at a single site on days D30, D90.
Contraindications: Post-Exposure Immunization: All contraindications are secondary in cases of suspected rabid
contamination.
Pre-Exposure and Booster Immunization: In case of pregnancy or acute febrile illness, the vaccination should be
differed.
Side Effects: Local minor reactions eg, redness and slight induration at the injection site. Rare febrile reactions.
Nursing Consideration: Cases of true allergy to streptomycin &/or neomycin. Do not use the intradermal route in
patients receiving long-term corticosteroid or other immunosuppressive therapy or chloroquine, immunocompromised
patients, patients w/ severe wounds esp to head & neck.
Contents:
Dosage:
Contraindications: Hypersensitivity to any component of the vaccine, including thimerosal, a mercury
derivative, is a contraindication to receipt of Tetanus Toxoid Adsorbed manufactured by Aventis Pasteur Inc.
(See DESCRIPTION section.)
It is a contraindication to use this vaccine after anaphylaxis or other serious allergic reaction following a
previous dose of this vaccine, any other tetanus toxoid-containing vaccine, or any component of this
vaccine. Because of uncertainty as to which component of the vaccine may be responsible, no further
vaccination with a tetanus component should be carried out. Alternatively, such individuals may be referred
to an allergist for evaluation if further immunizations are to be considered.
convulsions (seizures)
fever over 103 °F (39.4 °C)
headache (severe or continuing)
sleepiness (excessive)
swelling, blistering, or pain at place of injection (severe or continuing)
swelling of glands in armpit
unusual irritability
vomiting (severe or continuing)
Redness or hard lump at place of injection
Less common
Adverse Reaction:
Nursin
Contents: Tetanus Ig G
Adverse Reaction: Chills, headache, fever, nausea, vomiting, allergic reactions, dizziness, low BP, arthralgia &
moderate low back pain.
Nursing Consideration: Closely monitor & carefully observe patients for any adverse events for at least 20 min
after administration. Suspicion of allergic or anaphylactic shock requires immediate discontinuation of of the inj.
Pregnancy & lactation.
Brand Name:
Contents:
Indication / Action:
Dosage:
Contraindications:
Adverse Reaction:
Nursing Consideration: